Skip to main navigation Skip to search Skip to main content

Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening Heart Failure or Cardiovascular Death in Patients with Chronic Heart Failure with Reduced Ejection Fraction

Project: Research

Project Details

StatusFinished
Effective start/end date07/12/17 → 07/12/21

Funding

  • AstraZeneca Pharmaceuticals LP: $57,905.50